MedTrace Logo

SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia

NCT00110838 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2006-07-21

No results posted yet for this study

Summary

The objective of the SOFA trial is to investigate whether supplemental intake of n-3 polyunsaturated fatty acids (n-3 PUFA) from fish oil can reduce the recurrence of life-threatening ventricular arrhythmias in patients with an implantable cardioverter defibrillator (ICD).

Conditions

Interventions

PROCEDURE

Supplementation with fish oil versus placebo

Sponsors & Collaborators

  • SEAFOODplus

    collaborator OTHER

  • Wageningen Centre for Food Sciences

    lead OTHER

Principal Investigators

  • Evert G Schouten, MD, PhD · Wageningen Centre for Food Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Completion
2005-01-31

Countries

  • Austria
  • Belgium
  • Czechia
  • Germany
  • Netherlands
  • Poland
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00110838 on ClinicalTrials.gov